GlassScriptPhysician profile
Nathan Evin Marshall
NPI 1548529639
$21,450.56
in general payments reported to CMS, 2019-2025
13 companies · $1,474 in 2025
The $1,474 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,190 · 2020: $2,988 · 2021: $5,574 · 2023: $3,169 · 2024: $1,056 · 2025: $1,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,795 · Food and Beverage: $1,903.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,795.14 |
| Food and Beverage | $1,903.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $15,078.05 | 2019-2025 | |
| Pinnacle, INC | $4,475.22 | 2019-2025 | |
| Stryker Corporation | $1,533.79 | 2019-2025 | Gamma, Ortholoc 3di, Augment Injectable |
| Zimmer Biomet Holdings, INC. | $94.34 | 2019 | |
| Djo, LLC | $90.00 | 2019 | |
| Depuy Synthes Sales INC. | $47.11 | 2019 | |
| Ferring Pharmaceuticals INC. | $29.40 | 2019-2020 | |
| Linvatec Corporation | $21.48 | 2025 | Biobrace 23mm |
| Bioventus LLC | $19.28 | 2020 | |
| Pacira Therapeutics, INC. | $18.66 | 2019 | |
| Fidia Pharma USA INC. | $15.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.95 | 2019 | |
| Wright Medical Technology, INC. | $13.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.